ReportsnReports – Product Profiles: Asthma/COPD – Novel Combinations Edge Closer to Market
Despite a number of well-established therapies, the asthma and COPD pipeline remains highly active. A number of products have progressed in the pipeline and significant new data have been presented at this year’s respiratory conferences. Numerous product launches are expected in the next 10 years, which will fragment the markets, although a handful of companies will maintain market dominance.
View full press release